Charles Kummeth

Charles Kummeth

Chairman of the Board of DirectorsatBIO-TECHNE· In proxies 2021–2025

Pay in FY2023+99% from the year before · BIO-TECHNE stock -5.6% the same year

Charles Kummeth was paid $30.6M in FY2023 (Jun), up 99%. BIO-TECHNE stock fell 5.6% that year.

Pay$100 in the stock at the end of FY20 → $125
Pay is from the Summary Compensation Table of each BIO-TECHNE proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Quantum-SiPublic company · 1 yr
    • Chairman of the Board of Directors2025 – Present · 1 yrNo stock prices for these years
  2. BIO-TECHNEPublic company · 5 yr
    • Former President and CEO2021 – Present · 5 yrStock in role +12%
  3. Orthofix MedicalPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Gentherm, Inc.Public company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • BIO-TECHNEDirector · 10 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

Two people shown as one, or a wrong number?